Analysis of latency in cattle after inoculation with a temperature sensitive mutant of bovine herpevirus 1 (RLB106)

Vaccine

Volumn 18, Issue 27, 2000, Pages 3185-3195

  Jones, C ^a   Newby, T J ^b   Holt, T ^a   Doster, A ^a   Stone, M ^a   Ciacci Zanella, J ^a   Webster, C J ^b   Jackwood, M W ^c  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b PFIZER INC   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

Author keywords

Bovine herpes virus; Latency; Vaccine

Indexed keywords

DEXAMETHASONE; HERPES VACCINE; NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOVINE HERPES VIRUS; CATTLE; CONTROLLED STUDY; MUTANT; NONHUMAN; PRIORITY JOURNAL; SEROCONVERSION; TEMPERATURE SENSITIVE MUTANT; VIRUS LATENCY;

EID: 0034662390     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00106-7     Document Type: Article

References (32)

1. Tikoo S.K., Campos M., Babiuk L.A. Bovine herpesvirus 1 (BHV-1): biology, pathogenesis, and control. Advances in Virus Research. 45:1995;191-223.
2. Wyler R., Engels M., Schwyzer M. Infectious bovine rhinotracheitis/vulvovaginitis (BHV-1). Witman G. Herpesvirus diseases of cattle, horses, and pigs. 1989;1-72 Kluwer, Boston.
3. Kahrs R.F. Infectious bovine rhinotracheitis: a review and update. J. Am. Vet. Med. Assoc. 171:1977;1055.
4. Lupton H.W., Reed D.E. Evaluation of experimental subunit vaccines for infectious bovine rhinotracheitis. Am. J. Vet. Res. 41:1980;383-390.
5. Straub O.C. Infectious bovine rhinotracheitis virus. Dinter Z., Morin B. Virus infections of ruminants. 1990;71-109 Elsevier, Amsterdam.
6. Wuyckhuise L, Van Bosch J, Franken P, Hage J, Verhoeff J, Zimmer G. The prevalence of infectious bovine rhinotracheitis (IBR) in the Netherlands. In: Proc. 18th World Buiatrics Congress, Bologna, Italy. 1994;2:1439-42.
7. Castrucci G., Martin W.B., Frigeri F., Ferrari M., Salvatori D., Tagliati S., Cuteri V. A serological survey of bovine herpesvirus-1 infection in selected dairy herds in northern and central Italy. Comp. Immun. Microbiol. Infect. Dis. 20:1997;315-317.
8. Jones C. Alphaherpesvirus latency: its role in disease and survival of the virus in nature. Advances in Virus Research. 51:1998;47-99.
9. Hinkley S., Hill A.B., Srikumaran S. Bovine herpesvirus-1 infection affects the peptide transport activity in bovine cells. Virus Res. 53:1998;91-96.
10. Winkler MTC, Doster A, Jones C. Bovine herpesvirus-1 can infect CD4+ T lymphocytes and induce programmed cell death during acute infection of cattle. J Virology 1999;73:8657-8668.
11. Van Drunen den Littel.-van Hurk S., Tikoo S.K., Liang X., Babiuk L.A. Bovine herpesvirus-1 vaccines. Immunology and Cell Biology. 71:1993;405-420.
12. Thiry E., Brochier B., Saliki J., Pirak M., Pastoret P.P. Excretion and reexcretion of thermosensitive and wild type strains of infectious bovine rhinotracheitis virus after co-infection or two successive infection. Vet. Microbiol. 10:1985;371-380.
13. Zygraich N., Lobmann M., Vascoboinic E., Berge E., Huygelen C. In vivo and in vitro properties of a temperature sensitive mutant of infectious bovine rhinotracheitis virus. Res. Vet. Sci. 16:1974;328-335.
14. Neetleton P.F., Sharp J.M. Infectious bovine rhinotracheitis virus excretion after vaccination. Vet. Rec. 107:1980;379.
15. Kucera C.J., White R.G., Beckenhauer W.H. Evaluation of the safety and efficacy of an intranasal vaccine containing a temperature-sensitive strain of infectious bovine rhinotracheitis virus. Am. J. Vet. Res. 39:1978;607-610.
16. Cravens R.L., Ellsworth M.A., Sorensen C.D., White A.K. Efficacy of a temperature-sensitive modified-live bovine herpesvirus type-1 vaccine against abortion and stillbirth in pregnant heifers. J. Am. Vet. Med. Assoc. 208:1996;2031-2034.
17. Talens L.T., Beckenhauer W.H., Thurber E.T. Efficacy of viral components of a nonabortigenic combination vaccine for prevention of respiratory and reproductive system diseases in cattle. J. Am. Vet. Med. Assoc. 194:1989;1273-1280.
18. Schang L.M., Jones C. Analysis of bovine herpes virus 1 transcripts during a primary infection of trigeminal ganglia of cattle. J. Virology. 71:1997;6786-6795.
19. Lorenz R.J., Bogel K. Methods of calculation. Kaplan M.M., Koprowski H. Laboratory techniques in rabies. 1973;321-329 World Health Organization, Geneva, Switzerland.
20. Galeota J.A., Flores E.F., Kit S., Osorio F.A. A quantitative study of the efficacy of a deletion mutant bovine herpesvirus-1 differential vaccine in reducing the establishment of latency by wildtype virus. Vaccine. 15:1997;123-128.
21. Hossain A., Schang L.M., Jones C. Identification of the gene products encoded by the latency-related gene of bovine herpesvirus 1. J. Virol. 69:1995;5345-5352.
22. Brown G.A., Field H.J. Experimental reactivation of bovine herpesvirus 1 (BHV-1) by means of corticosteriods in an intranasal rabbit model. Arch. Virol. 112:1990;81-101.
23. Homan E.J., Easterday B.C. Experimental latent and recrudescent bovine herpesvirus 1 infections in calves. Am. J. Vet. Res. 44:1983;309-313.
24. Rock D., Lokensgard J., Lewis T., Kutish G. Characterization of dexamethasone-induced reactivation of latent bovine herpesvirus 1. J. Virol. 66:1992;2484-2490.
25. Sheffy B.E., Davies D.H. Reactivation of a bovine herpesvirus after corticosteroid treatment. Proc. Soc. Exp. Biol. Med. 140:1972;974-976.
26. Whetstone C.A., Miller J.M. Two different strains of an alphaherpesvirus can establish latency in the same tissue of the host animal: evidence from bovine herpesvirus 1. Arch. Virol. 107:1989;27-34.
27. Mweene A.S., Okazaki K., Kida H. Detection of viral genome in non-neural tissue of cattle experimentally infected with bovine herpesvirus 1. Jpn. J. Vet. Res. 44:1996;165-174.
28. Kaashoek M.J., Rijsewijk F.A., Oirschot J.T. Persistence of antibodies against bovine herpesvirus 1 and virus reactivation two to three years after infection. Vet. Microbiol. 53:1996;103-110.
29. Jericho K.W.F., Yates W.D.G., Babiuk L.A. Bovine herpesvirus-1 vaccination against experimental bovine herpesvirus-1 and Pasteurella haemolytica respiratory tract infection: onset of protection. Am. J. Vet. Res. 43:1982;1776-1780.
30. Sutton M.L. Rapid onset of immunity in cattle after intramuscular injection of a modified-live-virus IBR vaccine. Vet. Med. 75:1980;1447-1456.
31. Isreal B.A., Marshall R.L., Letchworth G.L., Letchworth G.J. Epitope specificity and protective efficacy of the bovine immune response to bovine herpesvirus-1 glycoprotein vaccines. Vaccine. 6:1988;249-256.
32. Todd J.D., Volenec F.J., Patton I.M. Intranasal vaccination against infectious bovine rhinotracheitis: studies on early onset of protection and use of the vaccine in pregnant cows. Am. J. Vet. Res. 159:1971;1370-1374.